Abstract: The removable seed tray is quickly and easily removable from a removable bird feeder base that is attached to the main tubular body of a bird feeder. The seed tray effectively serves the function of a seed tray while also permitting access to the portions of the removable base to permit the removable base to be detached from the tubular bird feeder body while the seed tray remains attached thereto.

Abstract: The removable seed tray is quickly and easily removable from a removable bird feeder base that is attached to the main tubular body of a bird feeder. The seed tray effectively serves the function of a seed tray while also permitting access to the portions of the removable base to permit the removable base to be detached from the tubular bird feeder body while the seed tray remains attached thereto.

Abstract: Compounds in accord with Formula I: wherein R1, R2, R3 and R4 are as defined in the specification, pharmaceutically acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.

Abstract: Compounds in accord with Formula I: wherein R1, R2, R3 and R4 are as defined in the specification, pharmaceutically acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.

Abstract: Compounds in accord with Formula I: wherein R1, R2, R3 and R4 are as defined in the specification, pharmaceutically acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.

Abstract: Compounds in accord with Formula I: wherein R1, R2, R3 and R4 are as defined in the specification, pharmaceutically acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.

Abstract: Compounds in accord with Formula I: wherein R1, R2, R3 and R4 are as defined in the specification, pharmaceutically acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.

Abstract: Compounds in accord with Formula I: wherein R1, R2, R3 and R4 are as defined in the specification, pharmaceutically acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.

Abstract: Disclosed herein is at least one piperidine derivative, at least one pharmaceutical composition comprising at least one piperidine derivative disclosed herein for treating at least one histamine H3 receptor associated condition therewith

Abstract: Compounds in accord with Formula I: wherein R1, R2, R3 and R4 are as defined in the specification, pharmaceutically acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.

Abstract: Compounds in accord with Formula I: wherein R1, R2, R3 and R4 are as defined in the specification, pharmaceutically acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.

Abstract: Compounds having the following structure wherein R1, R2, R3, R4, R5, R6, R7 m and n are as defined in the specification, in vivo-hydrolysable precursors thereof, pharmaceutically-acceptable salts thereof, the use in therapy and pharmaceutical compositions and methods of treatment using the same.

Abstract: A cup includes a liquid storage chamber and a separate medicine storage container.

Abstract: According to the present disclosure, a monolithic medicine dropper, for storing and dispensing liquids, includes a first portion resiliently compressible at one end. Also included is at least a second portion fluidly connected with the first portion and being essentially rigid and hollow and having an opening. At least one of the portions includes written indicia thereon indicating liquid capacities and content levels of the dropper.

Abstract: A monolithic container, for storing and dispensing medicines. The cup has a plurality of spaced-apart stepped increments and indicia for indicating capacities and content levels of the cup.

Abstract: The present disclosure relates to a monitor for sensing and transmitting sounds in a baby's vicinity. The monitor includes a housing having a base and two substantially spaced-apart legs, the housing enclosing acoustical and electrical means for sensing and transmitting the sounds. The monitor is mountable on a support by straddling the support with the substantially spaced-apart legs. The present disclosure also relates to a sound monitoring system. The system includes the monitor, a receiver, and a charger. Further, the present disclosure relates to a method of securedly and releasably mounting the monitor to a support.

Abstract: The present application describes nitrogen containing heterobicyclics and derivatives thereof, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa.

Abstract: The present invention is directed to certain novel compounds represented by structural Formula (I) or pharmaceutically acceptable salt forms thereof, wherein R1, R5, R6, R7, R8, R9, X, b, k, and n, and the dashed lines are described herein. The invention is also concerned with pharmaceutical formulations comprising these novel compounds as active ingredients and the use of the novel compounds and their formulations in the treatment of certain disorders. The compounds of this invention are serotonin agonists and antagonists and are useful in the control or prevention of central nervous system disorders including obesity, anxiety, depression, psychosis, schizophrenia, sleep disorders, sexual disorders, migraine, conditions associated with cephalic pain, social phobias, and gastrointestinal disorders such as dysfunction of the gastrointestinal tract motility.

Abstract: The present invention is directed to certain novel compounds represented by structural Formula (I) 1

Abstract: The present invention is directed to certain novel compounds represented by structural Formula (I) or pharmaceutically acceptable salt forms thereof, wherein is R1, R6a, R6b, R7, R8, R9, X, b, m, and n are described herein. The invention is also concerned with pharmaceutical formulations comprising these novel compounds as active ingredients and the use of the novel compounds and their formulations in the treatment of certain disorders. The compounds of this invention are serotonin agonists and antagonists and are useful in the control or prevention of central nervous system disorders including obesity, anxiety, depression, psychosis, schizophrenia, sleep disorders, sexual disorders, migraine, conditions associated with cephalic pain, social phobias, and gastrointestinal disorders such as dysfunction of the gastrointestinal tract motility.